Top Medical News
Stephen Padilla, 6 hours ago
Low-fat, weight-reducing diets may prevent premature all-cause mortality in adults with obesity, according to the results of a recent systematic review and meta-analysis.
9 hours ago
Combination treatment with dulaglutide plus glargine may provide additional benefits that are relevant to patients with type 2 diabetes mellitus (T2DM) and inadequate glycaemic control, such as weight-related quality-of-life measures, compared with glargine alone, according to data from the AWARD-9 study.
Tristan Manalac, Yesterday
In obese patients with type 2 diabetes mellitus (T2DM), bariatric surgery appears to significantly improve diabetic nephropathy, a recent study from Singapore has shown.
Diet plays a significant role in the development and prevention of type 2 diabetes (T2D), according to a recent study which has found a strong association between several circulating dietary biomarkers and glucose tolerance status (GTS) after correction for known T2D risk factors.
2 days ago
Child adiposity and cardiometabolic outcomes are associated with child but not maternal snoring, a recent study finds. Moreover, there is a cross-sectional relationship between child adiposity and other cardiometabolic outcomes.
2 days ago
Consuming about four or more servings of dark-green leafy vegetables, as well as corn and tubers, every day may confer benefits for low-density lipoprotein cholesterol in early postmenopausal women, a study from Hong Kong has shown.
Pearl Toh, 4 days ago
An initial strategy of 1-year romosozumab followed by alendronate is superior over alendronate alone in reducing new vertebral fractures in postmenopausal women with osteoporosis at high risk for fracture, according to the ARCH* study.
Special Reports
05 Apr 2017
At a recent lunch symposium held in conjunction with the 1st Malaysian Advances in Women’s Health Congress 2016, Professor Dr Jamiyah Hassan imparted clinical updates and strategies for the optimization of hormone replacement therapy in menopausal women. Highlights from her presentation are summarized below.
16 Mar 2017
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
20 Jan 2017
At the recent Malaysian Osteoporosis Society 2016 Clinical Practice Guideline (CPG) Meeting held on the 8th of October 2016 at Ibis Styles Ipoh, Dr Hew Fen Lee and Professor Dr Chan Siew Pheng presented clinical guidance on the management of osteoporosis, and discussed whether the benefits of treatment outweigh the risks.
04 Jan 2017
At the Diabetes Asia 2016 Conference organized by the National Diabetes Institute, Professor Jean Claude Mbanya presented the case for why gliclazide modified release (MR; Diamicron® MR, Servier) should be the treatment of choice for early and aggressive control of type 2 diabetes (T2D).
16 Dec 2016
BASALOG – Insulin glargine (rDNA) 100 IU/mL soln for inj (cartridge) – CCM Pharmaceuticals
16 Dec 2016
INVOKANA – Canagliflozin hemihydrate 100 mg and 300 mg FC tab – Johnson & Johnson (Janssen)
Pearl Toh, 07 Dec 2016
Preventing hypertension, diabetes, and obesity, which are the major risk factors for heart failure (HF), by ages 45 and 55 years may lower risks of incident HF and prolong HF-free survival, suggests data from the Cardiovascular Disease Lifetime Risk Pooling Project.
Conference Reports
Pearl Toh, 07 Oct 2017
Older age, presence of multiple comorbidities, and longer length of hospital stay, rather than difference in glycaemic control, were associated with an increased risk of 1-year death following admission with severe hypoglycaemia in patients with diabetes, according to a Singapore study.
Elaine Soliven, 02 Oct 2017
The use of continuous glucose monitoring (CGM) is associated with a decreased amount of time spent in hypoglycaemia in patients with type 1 diabetes (T1D), according to a study presented at EASD 2017.
Pearl Toh, 01 Oct 2017
Adding continuous glucose monitoring (CGM) to conventional finger-prick test during pregnancy increases the time spent in the recommended glycaemic target range and improves neonatal health outcomes in patients with type 1 diabetes (T1D) compared with traditional test alone, according to the CONCEPTT* study presented at EASD 2017.
Pearl Toh, 27 Sep 2017
Dapagliflozin improves glycaemic control with sustained weight loss without an increased risk of diabetic ketoacidosis (DKA) in patients with type 1 diabetes (T1D) who are inadequately controlled with insulin, according to the DEPICT-1* study.
Roshini Claire Anthony, 26 Sep 2017

Once-weekly doses of the glucagon-like peptide-1 receptor agonist exenatide plus insulin glargine improved glucose control and weight loss in patients whose type 2 diabetes (T2D) was uncontrolled on basal insulin and metformin, according to findings from the DURATION-7* trial.

Audrey Abella, 26 Sep 2017
The novel, G-protein coupled receptor 119 (GPR119) agonist DS-8500a demonstrated dose-dependent glucose-lowering effects and favourable improvements in lipid parameters that extended up to 12 weeks in Japanese patients with type 2 diabetes mellitus (T2D), according to data presented at EASD 2017.
25 Sep 2017
Podcast: Prof Melanie Davies talks about the novel dual SGLT1/2 inhibitor sotagliflozin for T1D
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!